174 related articles for article (PubMed ID: 7110545)
1. Limitations of high dose intra-arterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) chemotherapy for malignant gliomas.
Kapp J; Vance R; Parker JL; Smith RR
Neurosurgery; 1982 Jun; 10(6 Pt 1):715-9. PubMed ID: 7110545
[No Abstract] [Full Text] [Related]
2. Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma.
Johnson DW; Parkinson D; Wolpert SM; Kasdon DL; Kwan ES; Laucella M; Anderson ML
Neurosurgery; 1987 Apr; 20(4):577-83. PubMed ID: 3587550
[TBL] [Abstract][Full Text] [Related]
3. Superselective cerebral arterial infusion of BCNU in high-grade glioma: the radiologist's point of view.
Fontaine S; Théron J; Melanson D; Villemure JG; Emrich J; Raymond J; Ethier R
Can Assoc Radiol J; 1988 Sep; 39(3):178-81. PubMed ID: 2971050
[TBL] [Abstract][Full Text] [Related]
4. Neurological deficit after carotid infusion of cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) for malignant glioma: an analysis of risk factors.
Kapp JP; Sanford RA
Neurosurgery; 1986 Nov; 19(5):779-83. PubMed ID: 3785625
[TBL] [Abstract][Full Text] [Related]
5. Potentials and limitations of a clonogenic cell assay for human brain tumors.
Rosenblum ML; Dougherty DV; Deen DF; Wilson CB
Cancer Treat Rep; 1981; 65 Suppl 2():61-6. PubMed ID: 7346148
[TBL] [Abstract][Full Text] [Related]
6. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy for the treatment of malignant gliomas of the brain: a preliminary report.
Safdari H; Mompeon B; Dubois JB; Gros C
Surg Neurol; 1985 Nov; 24(5):490-7. PubMed ID: 4049223
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of superselective intra-arterial and intravenous [11C]BCNU evaluated by PET.
Tyler JL; Yamamoto YL; Diksic M; Théron J; Villemure JG; Worthington C; Evans AC; Feindel W
J Nucl Med; 1986 Jun; 27(6):775-80. PubMed ID: 3486962
[TBL] [Abstract][Full Text] [Related]
8. Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system.
Greenberg HS; Ensminger WD; Chandler WF; Layton PB; Junck L; Knake J; Vine AK
J Neurosurg; 1984 Sep; 61(3):423-9. PubMed ID: 6747681
[TBL] [Abstract][Full Text] [Related]
9. Superselective intracerebral chemotherapy of malignant tumours with BCNU. Neuroradiological considerations.
Théron J; Villemure JG; Worthington C; Tyler JL
Neuroradiology; 1986; 28(2):118-25. PubMed ID: 3703233
[TBL] [Abstract][Full Text] [Related]
10. Complications associated with intra-arterial BCNU administered in combination with vincristine and procarbazine for the treatment of malignant brain tumors.
Bremer AM; Kleriga E; Nguyen TQ; Balsys R; Northup HM; Gonzalez N; Duarte P; Miller RI
J Neurooncol; 1984; 2(2):129-32. PubMed ID: 6481425
[TBL] [Abstract][Full Text] [Related]
11. Solvent systems for intracarotid 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) infusion.
Ross RL; Kapp JP; Hochberg F; Krull IS; Ding XD; Selavka C
Neurosurgery; 1983 May; 12(5):512-4. PubMed ID: 6866232
[TBL] [Abstract][Full Text] [Related]
12. Effect of intra-arterial cisplatin and 1,3-bis(2chloroethyl)-1-nitrosourea (BCNU) dosage on radiographic response and regional toxicity in malignant glioma patients: proposal of a new method of intra-arterial dosage calculation.
Bobo H; Kapp JP; Vance R
J Neurooncol; 1992 Jul; 13(3):291-9. PubMed ID: 1517805
[TBL] [Abstract][Full Text] [Related]
13. Orbital angiographic changes after intracarotid BCNU chemotherapy.
Gebarski SS; Greenberg HS; Gabrielsen TO; Vine AK
AJNR Am J Neuroradiol; 1984; 5(1):55-8. PubMed ID: 6421125
[TBL] [Abstract][Full Text] [Related]
14. Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-demethyl-1-O-(4,6-O-2-thenylidene-beta-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumors.
Stewart DJ; Grahovac Z; Benoit B; Addison D; Richard MT; Dennery J; Hugenholtz H; Russell N; Peterson E; Maroun JA
Neurosurgery; 1984 Dec; 15(6):828-33. PubMed ID: 6392925
[TBL] [Abstract][Full Text] [Related]
15. The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma.
Nagpal S
Neurosurg Clin N Am; 2012 Apr; 23(2):289-95, ix. PubMed ID: 22440872
[TBL] [Abstract][Full Text] [Related]
16. Reduced systemic drug exposure by combining intra-arterial chemotherapy with hemoperfusion of regional venous drainage.
Oldfield EH; Dedrick RL; Yeager RL; Clark WC; DeVroom HL; Chatterji DC; Doppman JL
J Neurosurg; 1985 Nov; 63(5):726-32. PubMed ID: 4056874
[TBL] [Abstract][Full Text] [Related]
17. Intracarotid BCNU for glioma.
Wolpert SM
Neurosurgery; 1987 Aug; 21(2):270. PubMed ID: 3658141
[No Abstract] [Full Text] [Related]
18. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and systemic chemotherapy for malignant gliomas: a follow-up study.
West CR; Avellanosa AM; Barua NR; Patel A; Hong CI
Neurosurgery; 1983 Oct; 13(4):420-6. PubMed ID: 6314173
[TBL] [Abstract][Full Text] [Related]
19. Supraophthalmic carotid infusion for recurrent glioma: rationale, technique, and preliminary results for cisplatin and BCNU.
Kapp JP; Vance RB
J Neurooncol; 1985; 3(1):5-11. PubMed ID: 2987427
[TBL] [Abstract][Full Text] [Related]
20. Intra-arterial BCNU chemotherapy for the treatment of malignant gliomas of the central nervous system: a preliminary report.
Greenberg HS; Ensminger WD; Seeger JF; Kindt GW; Chandler F; Doan K; Dakhil SR
Cancer Treat Rep; 1981; 65(9-10):803-10. PubMed ID: 7023671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]